Estradiol-17β influences brain development and is a potential neuroprotectant;Einfluss von östradiol-17β auf die hirnentwicklung und seine eigenschaften als neuroprotektivum

Journal fur Neurologie, Neurochirurgie und Psychiatrie

Volumn 3, Issue 2, 2002, Pages 34-39

  Rao, M L ^a   Kolsch H ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Female sex hormone; Neurotoxicity; Schizophrenia

Indexed keywords

ESTRADIOL;

ARTICLE; BRAIN DEVELOPMENT; DISEASE COURSE; DOPAMINERGIC SYSTEM; EMBRYO DEVELOPMENT; FEMALE; FETUS GROWTH; HUMAN; MALE; NEUROPROTECTION; NEUROTOXICITY; ONSET AGE; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SEX DIFFERENCE;

EID: 0036286565     PISSN: 16081587     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. A role for ovarian hormones in sexual differentiation of the brain
2. Male-like sexual behaviour of female rats with unilateral lesions in the hypothalamic ventromedial nuclear region
3. Effects of androgenic and oestrogenic hormones on mating behaviour in rams castrated before and after puberty
4. Steroid metabolising enzymes in the determination of brain gender
5. Estrogen and the developing mammalian brain
6. Effects of dihydrotestosterone and oestradiol on sexual differentiation in male rats
7. Microimplants of estradiol in the sexually dimorphic area of the hypothalamus activate ultrasonic vocal behavior in male Mongolian gerbils
8. A review of brain aromatase cytochrome P450
9. Sexual dimorphism in the developmental regulation of brain aromatase
10. Rat estradiol binding plasma protein (EBP)
11. Changes in alpha-fetoprotein and albumin synthesis rates and their levels during fetal and neonatal development of rat brain
12. Developmental profile of estrogen receptor mRNA in the preoptic area of male and female neonatal rats
13. Sexual dimorphism of the human brain - A review of the literature
14. Roles of steroid hormones and their receptors in structural organization in the nervous system
15. Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia
16. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia
17. Hyperdopaminergia in schizophreniform psychosis: A chronobiological study
18. Age-related changes in fibre composition of the human corpus callosum: Sex differences
19. The maturational theory of brain development and cerebral excitability in the multifactorially inherited manic-depressive psychosis and schizophrenia
20. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder
21. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia
22. Can estradiol modulate schizophrenic symptomatology?
23. An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia
24. Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line
25. Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids
26. Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain
27. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques
28. Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus
29. Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain
30. Gender and the expression of schizophrenia
31. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients
32. The role of estrogens in schizophrenia gender differences
33. Effects of gender and age on plasma levels of clozapine and its metabolites: Analyzed by critical statistics
34. Tardive dyskinesia in psychosis: Are women really more at risk?
35. A clinical trial of the effects of estrogen in acutely psychotic women
36. Hormone replacement therapy in postmenopausal women with schizophrenia: Positive effect on negative symptoms?
37. Neuroprotective effects of estrogens: Potential mechanisms of action
38. Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system
39. Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB
40. Novel variants in the promoter region of the CREB gene in schizophrenic patients
41. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia
42. Heritability of BDNF alleles and their effect on brain morphology in schizophrenia
43. Estradiol upregulates Bcl-2 expression in adult brain neurons
44. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos cmyc, bax, bcl-2, and bcl-x) in the hamster uterus
45. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia
46. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: Implications for Alzheimer's disease
47. Calcium - A life and death signal
48. New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro
49. New aspects of the mechanism of DNA fragmentation in apoptosis
50. 2+ transients in spines of CA1 pyramidal neurons from hippocampal slices
51. The glutamatergic dysfunction hypothesis for schizophrenia
52. Schizophrenia and glutamate
53. Treatment of negative and cognitive symptoms
54. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia
55. Human plasma glutathione peroxidase and symptom severity in schizophrenia
56. Low concentrations of estradiol reduce betaamyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells
57. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β
58. Erhöht postmenopausale östrogen-gestagen-substitution das endometriumkarzinom-risiko?
59. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
60. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk